Skip to main content
Top
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

Risk factors of renal dysfunction and their interaction in level-low lead exposure paint workers

Authors: Xiaojuan Wang, Huiling Liang, Yan Wang, Chang Cai, Jimeng Li, Xun Li, Mian Wang, Mengshi Chen, Xin Xu, Hongzhuan Tan

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

To explore the effect of low-level lead exposure on renal dysfunction in paint works, and analyze the interaction between low-level lead exposure and other influence factors of renal dysfunction.

Methods

Seven hundred forty seven workers from Sany Heavy Industry Company and Xiangjiang Kansai Paint Company who have been exposed to paint were chosen by random cluster sampling. Their blood lead level and Urine β2-micro globulin level (renal dysfunction) were tested,risk factors of renal dysfunction in paint workers and their interactions were analyzed.

Results

The prevalence of renal dysfunction was 12.37%. Risk factors of renal dysfunction in paint workers mainly included longer working years (OR = 1.699, 95% CI: 1.226~ 2.355), blood lead positive (OR = 2.847, 95% CI: 1.577~ 5.139) and hypertension (OR = 2.192, 95% CI: 1.103~ 4.359). Positive interaction existed between hypertension and low-level blood lead on renal dysfunction in paint workers, the RERI (Relative excess risk of interaction), API (Attributable proportions of interaction) and S(the synergy index) were 4.758, 54.5% and 2.604 respectively.

Conclusions

Low-level lead exposure and hypertension not only have independent effect on renal dysfunction in paint workers, but also had obvious positive interaction in paint workers. Interventions aimed at blood lead and blood pressure at the same time will better prenvent from renal dysfunction.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lanceraux E. Nephrite et arthrite saturnines: Coincidence de ces affections: Parallele avec la nephrite et l' arthrite gouteusses. Acrh de Gereales Medicines. 1881:641–7. Lanceraux E. Nephrite et arthrite saturnines: Coincidence de ces affections: Parallele avec la nephrite et l' arthrite gouteusses. Acrh de Gereales Medicines. 1881:641–7.
2.
go back to reference Lim YC, Chia KS, Ong HY, Ng V, Chew YL. Renal dysfunction in workers exposed to inorganic lead. Ann Acad Med Singap. 2001;30:112–7.PubMed Lim YC, Chia KS, Ong HY, Ng V, Chew YL. Renal dysfunction in workers exposed to inorganic lead. Ann Acad Med Singap. 2001;30:112–7.PubMed
3.
go back to reference Wang VS, Lee MT, Chiou JY, Guu CF, Wu CC, Wu TN, Lai JS. Relationship between blood lead levels and renal function in lead battery workers. Int Arch Occup Environ Health. 2002;75:569–75.CrossRefPubMed Wang VS, Lee MT, Chiou JY, Guu CF, Wu CC, Wu TN, Lai JS. Relationship between blood lead levels and renal function in lead battery workers. Int Arch Occup Environ Health. 2002;75:569–75.CrossRefPubMed
4.
go back to reference Sommar JN, Svensson MK, Björ BM, et al. End-stage renal disease and low level exposure to lead, cadmium and mercury: a population-based, prospective nested case-referent study in Sweden. Environ Health. 2013;12:9.CrossRefPubMedPubMedCentral Sommar JN, Svensson MK, Björ BM, et al. End-stage renal disease and low level exposure to lead, cadmium and mercury: a population-based, prospective nested case-referent study in Sweden. Environ Health. 2013;12:9.CrossRefPubMedPubMedCentral
5.
go back to reference Chung SJ, Chung JH, Kim SJ, et al. Blood lead and cadmium levels and renal function in Korean adults. Clin Exp Nephrol. 2014;18:726–34.CrossRefPubMed Chung SJ, Chung JH, Kim SJ, et al. Blood lead and cadmium levels and renal function in Korean adults. Clin Exp Nephrol. 2014;18:726–34.CrossRefPubMed
6.
go back to reference Muntner P, He J, Vupputuri S, Coresh J, Batuman V. Blood lead and chronic kidney disease in the general United States population: results from NHANES III. Kidney Int. 2003;63:1044–50.CrossRefPubMed Muntner P, He J, Vupputuri S, Coresh J, Batuman V. Blood lead and chronic kidney disease in the general United States population: results from NHANES III. Kidney Int. 2003;63:1044–50.CrossRefPubMed
7.
go back to reference Wan XH, Lu LF. Diagnostics, vol. 346. Beijing: People's Medical Publishing House; 2013. Wan XH, Lu LF. Diagnostics, vol. 346. Beijing: People's Medical Publishing House; 2013.
8.
9.
go back to reference Zhang LX, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross- sectional survey. Lancet. 2012;379:815–22.CrossRefPubMed Zhang LX, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross- sectional survey. Lancet. 2012;379:815–22.CrossRefPubMed
10.
go back to reference Jameson K, Jick S, Hagberg KW, Ambegaonkar B, Giles A, O'Donoghue D. Prevalence and management of chronic kidney disease in primary care patients in the UK. Int J Clin Pract. 2014;68:1110–21.CrossRefPubMed Jameson K, Jick S, Hagberg KW, Ambegaonkar B, Giles A, O'Donoghue D. Prevalence and management of chronic kidney disease in primary care patients in the UK. Int J Clin Pract. 2014;68:1110–21.CrossRefPubMed
11.
go back to reference Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, Badawi A. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ. 2013;185:E417–23.CrossRefPubMedPubMedCentral Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, Badawi A. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ. 2013;185:E417–23.CrossRefPubMedPubMedCentral
12.
go back to reference Hallan SI, Drahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, Dekker FW. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006;333:1047.CrossRefPubMedPubMedCentral Hallan SI, Drahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, Dekker FW. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006;333:1047.CrossRefPubMedPubMedCentral
13.
go back to reference Li PK, Kwan BC, Leung CB, et al. Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong asymptomatic renal population and evaluation (SHARE) program. Kidney Int Suppl. 2005;67:11–7. Li PK, Kwan BC, Leung CB, et al. Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong asymptomatic renal population and evaluation (SHARE) program. Kidney Int Suppl. 2005;67:11–7.
14.
go back to reference Bello AK, Nwankwo E, Nw ENAM. Prevention of chronic kidney disease: a global challenge. Kidney Int Suppl. 2005;68:11–7.CrossRef Bello AK, Nwankwo E, Nw ENAM. Prevention of chronic kidney disease: a global challenge. Kidney Int Suppl. 2005;68:11–7.CrossRef
15.
go back to reference Yu CC, Lin JL, Lin-Tan DT. Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol. 2004;15:1016–22.CrossRefPubMed Yu CC, Lin JL, Lin-Tan DT. Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol. 2004;15:1016–22.CrossRefPubMed
16.
go back to reference Bao YS, Jia XB, Ji Y, Yang J, Zhao SL, Na SP. High prevalence and risk factors for kidney dysfunction in patients with atherosclerotic cardio-cerebrovascular disease. Q J Med. 2014;107:443–9.CrossRef Bao YS, Jia XB, Ji Y, Yang J, Zhao SL, Na SP. High prevalence and risk factors for kidney dysfunction in patients with atherosclerotic cardio-cerebrovascular disease. Q J Med. 2014;107:443–9.CrossRef
17.
go back to reference Bidani AK, Polichnowski AJ, Loutzenhiser R, Griffin KA. Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens. 2004;22:1–9.CrossRef Bidani AK, Polichnowski AJ, Loutzenhiser R, Griffin KA. Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens. 2004;22:1–9.CrossRef
Metadata
Title
Risk factors of renal dysfunction and their interaction in level-low lead exposure paint workers
Authors
Xiaojuan Wang
Huiling Liang
Yan Wang
Chang Cai
Jimeng Li
Xun Li
Mian Wang
Mengshi Chen
Xin Xu
Hongzhuan Tan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-5475-9

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue